Nautic Partners Makes Strategic Growth Investment in EmpiRx Health

Nautic Partners Completes Growth Investment in KabaFusion

February 2, 2026

Healthcare Services

Nautic Partners has completed a growth investment in KabaFusion, a national provider of home and alternative-site infusion services. KabaFusion’s clinician-led management team remains significant investors and will continue to lead the company while Novo Holdings exited its investment; the capital will support accelerated growth and expanded access to infusion care nationwide.

Enhanced Healthcare Partners Makes Growth Investment in Janus Health

March 21, 2023

Healthcare Services

Enhanced Healthcare Partners (EHP) announced a strategic growth investment in Janus, a provider of AI-enabled revenue cycle management (RCM) technology. The capital will support Janus' market expansion, product development and go-to-market initiatives to accelerate adoption across health systems and RCM service providers.

CGE Partners Invests in Datapharm

February 28, 2022

Pharmaceuticals

CGE Partners has made a growth investment in Datapharm, the UK-based provider of regulatory-driven medicines information and software (including the electronic medicines compendium, emc). The investment will partner with Datapharm's management to accelerate new product development, international expansion, and support strategic acquisitions.

Nautic Partners Makes Growth Investment in SPS Health

February 4, 2022

Healthcare Services

Nautic Partners has made a strategic growth investment in SPS Health to support the company's continued investment in technology, clinical and operational solutions for post-acute pharmacies and PBMs. The capital from Nautic (from its tenth fund) will help SPS expand its technology-enabled offerings and broaden its reach across long-term care, behavioral health, correctional and other specialty pharmacy markets.

One Equity Partners Completes Strategic Investment in InfuCare Rx

January 12, 2022

Healthcare Services

One Equity Partners (OEP) has completed a strategic investment in InfuCare Rx, a Fairfield, New Jersey–headquartered provider of specialty home infusion therapies and clinical therapy management. Financial terms were not disclosed; OEP said the capital will be used to accelerate growth, expand into new regions and scale InfuCare Rx's digital care management platform serving patients with complex chronic conditions.

Enhanced Healthcare Partners & Bourne Partners Strategic Capital Acquire Pharmaceutical Associates, Inc.

November 6, 2019

Pharmaceuticals

Enhanced Healthcare Partners (EHP), together with Bourne Partners Strategic Capital (BPSC), announced the acquisition of Pharmaceutical Associates, Inc. (PAI), a U.S. manufacturer of generic liquid and unit-dose pharmaceuticals. The investment will provide growth capital to expand PAI's manufacturing capacity, product lines and market footprint while leveraging BPSC's pharmaceutical network and EHP's healthcare investment experience.